About

Engineering the Future of the Genome

Gene Editing (also known as genome engineering) provides the fundamental toolkit for modifying the DNA or RNA of any organism. By enabling the precise addition, removal, or alteration of genetic material at targeted locations, these technologies are transforming our understanding of biology and therapeutics. Just as the field of genome engineering is rapidly evolving, so is our journal.

Gene Editing is a peer-reviewed, open-access journal dedicated to the rapid dissemination of high-impact research across all facets of genetic modification. We prioritize scientific originality, medical significance, and robust conclusions.

Research Scope & Aims

The journal welcomes submissions involving gene editing applications across Human Health, Animal Sciences, Plant Biology, Microorganisms, and Global Food Security. Our comprehensive scope covers:

1. Core Technologies

We publish advancements in the design and optimization of programmable nucleases, including but not limited to:

  • CRISPR-Cas Systems: CRISPR-Cas9, Cas12, Cas13, and prime editing.

  • Engineered Nucleases: TALENs, Zinc Finger Nucleases (ZFNs), and meganucleases.

  • Novel Tools: Emerging technologies for site-specific DNA/RNA modification and base editing.

2. Therapeutic Frontiers

We are particularly interested in translational research that advances clinical outcomes:

  • Gene Therapy: Viral and non-viral delivery systems for therapeutic gene transfer.

  • Genetic Correction: Precision editing for rare genetic disorders and monogenic diseases.

  • Engineered Immunotherapies: Development of CAR-T cells, TCR-engineered cells, and other synthetic immune-based therapies.

3. Molecular Foundations

Understanding the biological "why" behind the "how" is critical to our mission:

  • DNA Repair Pathways: Studies on Non-Homologous End Joining (NHEJ), Homology-Directed Repair (HDR), and microhomology-mediated repair.

  • Gene Biology: Functional genomics, epigenome editing, and the regulatory mechanisms of gene expression.

4. Applied Genetics & Bioengineering

We bridge the gap between laboratory innovation and real-world application:

  • Agricultural & Industrial Biotechnology: Development of GMOs for improved crop yield, pest resistance, and sustainable food supply.

  • Bioengineering Innovations: Synthetic biology approaches, pathway engineering, and high-throughput screening technologies.

Mission and Philosophy

The goal of Gene Editing is to modernize the research culture by providing a high-speed academic platform for this rapidly expanding field. We believe that scientific knowledge should be accessible to everyone without barriers.

Our Philosophy: Science should be open, accessible, and free.

Articles are available online at www.genediting.net. We are currently in the process of expanding our indexing presence in Science Citation Index Expanded (SCI-E), PubMed, and Google Scholar.

Innovation in Peer Review: The Interactive Rebuttal Process

Gene Editing introduces a streamlined, transparent peer-review and rebuttal workflow designed for the modern researcher. This system eliminates the "black box" of traditional publishing:

  • Real-Time Feedback: Authors receive reviewer feedback as soon as it is submitted, allowing for immediate revisions.

  • Accelerated Resubmission: By enabling authors to respond to referees promptly, we significantly shorten the cycle between submission and publication.

  • Instant Notifications: Our automated tracking system informs authors instantly via email regarding referee appointments and editorial decisions.

This innovation ensures that groundbreaking research reaches the global scientific community at the speed of discovery.

Editorial Leadership

We invite you to submit your original work.

Prof. Dr. Fatih Kocabaş Editor-in-Chief fatihkocabas@gmail.com

© Gene Editing | ISSN: 2687-640X | www.genediting.net